消息來源:中研院
截止日期:2013-11-12
Dear All,
We are pleased to inform you that Dr. Patrick Y. Lam will give a talk on November 12 (Tuesday).
Dr. Lam, a medicinal chemistry and drug discovery consultant at Lam Drug Discovery Consulting, has discovered a total of eight clinical candidates by leading groups or personal effort. He was the group leader/director responsible for the discovery of Eliquis®/Apixaban, a novel FXa inhibitor as a new anticoagulant medicine. Eliquis® has been approved for marketing in EU since May 2011.
Below is the lecture information and your attendance will be highly appreciated. Thank you very much.
-----------------------------------------------
GRC Lecture (11/12, Tuesday)
Time: 10:30 – 11:30 AM
Place: Auditorium, Genomics Research Center
Speaker & Topic:
Dr. Patrick Y. Lam
President,
Lam Drug Discovery Consulting, USA
Host: Dr. Y. S. Edmond Cheng 鄭義循 研究技師
演講地點:中央研究院基因體研究中心一樓演講廳